Preliminary Study of Microwave Tumoral Ablation Performances for the Treatment of Pulmonary, Renal and Bone Neoplasia.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1/PHASE2

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-09-30

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aims of this work were to assess the feasibility, efficacy, short-term outcome and safety of microwave ablation in the treatment of malignant bone, lung and renal tumors.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Transbronchial MWA for Pulmonary Tumors

NCT06969014

Lung Cancer

RECRUITING NA

Microwave Ablation With MRI-Guided SBRT Boost in Renal Cell Carcinoma

NCT02782715

Carcinoma, Renal Cell

TERMINATED PHASE1/PHASE2

Transbronchial vs Transthoracic Ablation for Early-stage Peripheral Lung Cancer

NCT06052098

Stage IA Lung Cancer

RECRUITING NA

ENB Guided RFA for Early-stage Peripheral Lung Cancer

NCT03009630

Lung Cancer

UNKNOWN NA

Thermal Ablation Combined With External Beam Radiation Therapy for Patients With Inoperable Non-Small Cell Lung Cancer > 3.5 cm in Size

NCT01028612

Non-small Cell Lung Cancer

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Tumor Bone Tumor Renal Tumor

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Renal tumor

Microwave ablation of renal tumor

Group Type EXPERIMENTAL

Microwave ablation with Acculis Accu2i pMTA Applicator

Intervention Type DEVICE

Lung tumor

Microwave ablation of lung tumor

Group Type EXPERIMENTAL

Microwave ablation with Acculis Accu2i pMTA Applicator

Intervention Type DEVICE

Bone tumor

Microwave ablation of bone tumor

Group Type EXPERIMENTAL

Microwave ablation with Acculis Accu2i pMTA Applicator

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Microwave ablation with Acculis Accu2i pMTA Applicator

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and women \> 18 years old
* Thermoablation indication of renal neoplasia, bone or lung decided during a multidisciplinary consultation meeting - Generally speaking, the indications are: (i) inoperable primary malignant tumor or secondary malignant tumor, (ii) resectable primary malignant renal and lung tumor with medical contraindication to surgery or general anesthesia
* Signature of informed consent for participation
* Affiliation to a social security scheme or French beneficiary of such a regime.

Exclusion Criteria

* Contraindication to percutaneous thermoablation
* Renal or lung tumor up to 4 cm
* Women of childbearing age, premenopausal, non-sterilized surgically, and unwilling to use effective contraception
* Legal incapacity or legal capacity limited
* Person unlikely to cooperate in the study and / or low degree of cooperation expected by the investigator
* Person without health insurance
* Pregnant women

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No